Lithium Carbonate
- Product NDC
- 62756-430
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lithium Carbonate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA091027
- Marketing category
- ANDA
- Substance
- LITHIUM CARBONATE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 62756-430-08 | 100 TABLET in 1 BOTTLE (62756-430-08) | 20100708 | | No | Historical |
| 62756-430-18 | 1000 TABLET in 1 BOTTLE (62756-430-18) | 20100708 | | No | Historical |
| 62756-430-83 | 30 TABLET in 1 BOTTLE (62756-430-83) | 20100708 | | No | Historical |
| 62756-430-88 | 100 TABLET in 1 BOTTLE (62756-430-88) | 20100708 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| d3284649-ed4c-4096-987b-4ac16b8278f2 | These highlights do not include all the information needed to use LITHIUM CARBONATE TABLETS safely and effectively. See full prescribing information for LITHIUM CARBONATE TABLETS. LITHIUM CARBONATE tablets, for oral use Initial U.S. Approval: 1970 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2023-10-02 | Human Prescription Drug Label | 9 |